COMMUNIQUÉS West-GlobeNewswire

VAYA™ Pharma Launches Vayarin® Plus Medical Food for the Management of ADHD in Adults and Adolescents
04/06/2018
New Non-Drug Medical Food Clinically Shown to Improve ADHD Behaviors in Adults COLUMBIA, MD., June 04, 2018 (GLOBE NEWSWIRE) -- VAYA™ Pharma, Inc. (VAYA™), a division of Frutarom, Industries Ltd. (LSE:FRUT) (TASE:FRUT) [...]
Mersana Presents Interim Dose-Escalation Data on XMT-1522 in Select Cancers at ASCO 2018
04/06/2018
Favorable Tolerability Profile and Early Signs of Efficacy Demonstrated First Disclosure of Clinical Data from Novel Dolaflexin Platform Mersana To Host Conference Call and Webcast Including Principal Investigator, [...]
TG Therapeutics, Inc. Announces Umbralisib Clinical Data Presentation at the 54th Annual Meeting of the American Society of Clinical Oncology
04/06/2018
CHICAGO, June 04, 2018 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ:TGTX), today announced updated clinical data from its ongoing Phase 2 study evaluating umbralisib (TGR-1202), the Company’s PI3K delta inhibitor, [...]
Stelis Biopharma and Oncobiologics to Unveil Bio2Source CDMO Offering at BIO 2018
04/06/2018
CRANBURY, N.J., June 04, 2018 (GLOBE NEWSWIRE) -- Stelis Biopharma and Oncobiologics, Inc. (NASDAQ:ONS) today announced that they will unveil a new contract development and manufacturing (“CDMO”) effort at BIO 2018 in [...]
CapsoVision Announces U.S. Distribution Partnership With PENTAX Medical
04/06/2018
The diagnostic and therapeutic endoscopy company will now sell CapsoVision capsule endoscopy solutions CapsoCam Plus® and CapsoCloud™ across the country SARATOGA, Calif., June 04, 2018 (GLOBE NEWSWIRE) -- Today Silicon [...]
Adverum Biotechnologies to Present at the 2018 Jefferies Global Healthcare Conference
04/06/2018
MENLO PARK, Calif., June 04, 2018 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. (Nasdaq:ADVM), a clinical-stage gene therapy company targeting unmet medical needs in serious rare and ocular diseases, announced today [...]
"This is Infertility" Releases New Episodes for Pride Month 2018
04/06/2018
NEW YORK, June 04, 2018 (GLOBE NEWSWIRE) -- This is Infertility , a podcast by Progyny, announced today the release of new episodes for Pride Month 2018. One episode, each highlighting how LGBTQ couples navigate the [...]
Oncolytics Biotech® Announces Poster Presentation Demonstrating the Ability of REOLYSIN® to Promote and Predict Response to Checkpoint Inhibitors at ASCO 2018 Annual Meeting
04/06/2018
CALGARY, Alberta and SAN DIEGO, June 04, 2018 (GLOBE NEWSWIRE) -- Oncolytics Biotech ® Inc. (TSX:ONC) (NASDAQ:ONCY), currently developing REOLYSIN ® (pelareorep), an intravenously delivered immuno-oncolytic virus [...]
New Data from Phase 1 Study of Ivosidenib or Enasidenib in Combination with Azacitidine Demonstrate Robust Responses and a Well Tolerated Safety Profile in Newly Diagnosed IDHm AML Patients
04/06/2018
- Safety Profile of Combination Therapies Consistent with Single Agent IDHm Inhibitors and Azacitidine - - ORR of 78%, CR Rate of 44% and CR/CRi/CRp Rate of 65% in the Ivosidenib Arm; Molecular Clearance Observed in 7 [...]
CytomX Therapeutics Presents Preliminary Clinical Proof-of-Concept Data from Probody™ Platform and CX-072 at 2018 ASCO Annual Meeting
04/06/2018
– PD-L1 Targeting Probody CX-072 Well Tolerated and Shows Antitumor Activity as Monotherapy and in Combination with Ipilimumab – – Company to Host Conference Call and Webcast Today Monday, June 4 th at 5:00 p.m. CT / 6: [...]
Analogic Announces Results for the Third Quarter Ended April 30, 2018
04/06/2018
Special Shareholder Meeting To Approve Altaris Transaction Scheduled for June 21, 2018 PEABODY, Mass., June 04, 2018 (GLOBE NEWSWIRE) -- Analogic Corporation (Nasdaq:ALOG), enabling the world's medical imaging and [...]
Galectin Therapeutics Inc. Announces Richard E. Uihlein Elected Chairman of the Board
04/06/2018
NORCROSS, Ga., June 04, 2018 (GLOBE NEWSWIRE) -- Galectin Therapeutics Inc. (NASDAQ:GALT), the leading developer of therapeutics that target galectin proteins, announced today that the directors elected Richard E. [...]
SELLAS Life Sciences Presents Interim Phase 1 Clinical Data of Galinpepimut-S (GPS) in Combination with Nivolumab to Treat Wilms Tumor 1 Positive (WT1+) Ovarian Cancer Patients at ASCO 2018
04/06/2018
1-year progression-free survival (PFS) rate of 70% with induction of serum levels of WT1 Antigen-Specific Immunoglobulin G (IgG) in 86% of patients treated with GPS in combination with programmed cell death protein-1 ( [...]
Marrone Bio Innovations Launches New CG Brand of Highly Effective Biological Solutions for Crop Protection in Cannabis and Home Gardens
04/06/2018
Smaller package sizes of Regalia® CG, Grandevo® CG and Venerate® CG address the most economically damaging pests and diseases in cannabis production and for home gardeners DAVIS, Calif., June 04, 2018 (GLOBE NEWSWIRE [...]
Progenics Pharmaceuticals Announces Presentation of Updated Data from the Pivotal Trial of AZEDRA® (iobenguane I 131) at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting
04/06/2018
NEW YORK, June 04, 2018 (GLOBE NEWSWIRE) -- Progenics Pharmaceuticals, Inc. (Nasdaq:PGNX), an oncology company developing innovative medicines and other products for targeting and treating cancer, announced updated [...]
New Interim Phase 2a Study Results Demonstrate Broad Clinical Activity of Portola Pharmaceuticals’ Oral SYK/JAK Inhibitor Cerdulatinib
04/06/2018
– Differentiated SYK-JAK Inhibitor Shows Efficacy in Patients with Heavily Pre-Treated B- and T-Cell Malignancies – – New Signal in AITL; Five Complete Responses for a Complete Response Rate of 71 Percent – – Data to be [...]
Natus Medical Board of Directors Mails Letter to Shareholders
04/06/2018
Recommends Voting on the WHITE Proxy Card FOR the Election of Doris Engibous and Robert Weiss Shareholders Should Not Vote for Removal of Chairman Robert Gunst Illustrates Highly-Qualified and Committed Directors with [...]
Interpace Diagnostics to Attend and Present at the 8th Annual LD Micro Invitational Conference
04/06/2018
PARSIPPANY, N.J., June 04, 2018 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (NASDAQ:IDXG) (“Interpace” or “the Company”), a fully integrated commercial and bioinformatics company that provides clinically [...]
Oxford Immunotec Announces Data Presentations for T-SPOT®.CMV Test at the 2018 American Transplant Congress
04/06/2018
OXFORD, United Kingdom and MARLBOROUGH, Mass., June 04, 2018 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq:OXFD), a global, high-growth diagnostics company, today announced that data from studies utilizing the [...]

Pages